Urinary Tract Carcinoma — Trials

Urinary Tract Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

852 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 326
Recruiting: 177
Ph III recruiting: 26
Growth YoY: +28.6%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (127)

clinicaltrialsPublishedShowing 1–7 of 7 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02968732	Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder	active not recruiting	N/A	65	Fox Chase Cancer CenterOTHER	1	Sep 21, 2026	clinicaltrials
NCT06414317	An Education and Navigation Support Tool to Improve Participation in Care Coordination Among Patients With Locally Advanced, Metastatic and Unresectable Bladder Cancer and Their Caregivers	active not recruiting	N/A	12	Roswell Park Cancer InstituteOTHER	1	Aug 25, 2026